US Patent Issued to CHIESI FARMACEUTICI on Nov. 11 for "Amino quinazoline derivatives as P2X3 inhibitors" (Italian Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,820, issued on Nov. 11, was assigned to CHIESI FARMACEUTICI S.P.A. (Parma, Italy).

"Amino quinazoline derivatives as P2X3 inhibitors" was invented by Paolo Bruno (Parma, Italy), Matteo Biagetti (Parma, Italy), Claudio Fiorelli (Parma, Italy), Daniela Pizzirani (Parma, Italy), Daniele Pala (Parma, Italy), Paolo Ronchi (Parma, Italy), Charles Baker-Glenn (Parma, Italy), Herve Van De Poel (Parma, Italy), Kim Louise Hirst (Parma, Italy) and Sara Guariento (Parma, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula I inhibiting P2X purinoceptor 3; particularly the invention relates to compounds that ...